The impact of COVID-19 on access to Parkinson's disease medication
A global survey of health professionals, led by Queen Mary University of London, has shown that during the COVID-19 pandemic, patients with Parkinson's disease in large parts of Asia, Africa, and Latin and South America experienced ...
Sep 21, 2020
0
4